6Mc Tavish D, Campoi-Richards D, Sorkin EM. Carvedilol: a review of its pharmacodynamic and phar-macokinetic properties and therapeutic efficacy[J].Drugs, 1998,45:232-245.
7Schiffrin E. Oxidative stress, nitric oxide synthase, and superoxide dismutase: a matter of imbalance underlies endothelial dysfunction in the human coronary circulation[J].Hypertension,2008,51(1):31-32.
8Douqhty RN, Whalley GA, Walsh HA, et al. Effects of carvedilol on left ventricular remodeling after acute myocardial infarction: the CAPRICORN Echo Substudy[J].Circulation,2004,109(2):201-206.
9Afonso RA, Patarrao RS, Macedo MP, et al. Carvedilol action is dependent on endogenous production of nitric oxide[J].2006,19(4):419-425.
10Nishioka K, Nakaqawa K, Umemura T, et al. Carvedilol improves endothelium-dependent vasodilation in patients with dilated cardiomyopathy[J].Heart,2007,93(2):247-248.
8Potgieter M,Pretorius E,Oberholzer HM.Qualitative electron microscopic analysis of cultured chick embryonic cardiac and skeletal muscle cells:the cellular effect of coenzyme q10 after exposure to triton x-100[J].Ultrastruct Pathol,2009,33(3):93-101.
9Triantafyllis AS,Kalogeropoulos AS,Rigopoulos AG,et al.Coronary artery ectasia and inflammatory cytokines:link with a predominant Th-2 immune response?[J].Cytokine,2013,64(1):427-432.
10Hrnciar J,Avdicova M,Gabor D,et al.Prevalence of metabolic syndrome,insulin resistance,and microvascular angina pectoris in 500consecutive patients referred to coronarography[J].Endocr Regul,2013,47(1):33-38.
